Dark matter: Developing a new nanoantioxidant-based therapeutic system for the treatment of age-related macular degeneration-Reference-Cited by-同舟云学术

Dark matter: Developing a new nanoantioxidant-based therapeutic system for the treatment of age-related macular degeneration

Published:2023-06 Issue: Volume:50 Page:101879
ISSN:1748-0132
Container-title:Nano Today
language:en
Short-container-title:Nano Today

Author:

Kwon Yong-Su,Voinov Maxim A.,Zheng Min,Smirnov Alex I.,Han Zongchao

Publisher

Elsevier BV

Subject

Pharmaceutical Science,General Materials Science,Biomedical Engineering,Bioengineering,Biotechnology

Reference59 articles.

1. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis;Wong;Lancet Glob. Health,2014

2. Recent developments in the treatment of age-related macular degeneration;Holz;J. Clin. Investig.,2014

3. The role of the reactive oxygen species and oxidative stress in the pathomechanism of the age-related ocular diseases and other pathologies of the anterior and posterior eye segments in adults;Nita;Oxid. Med. Cell. Longev.,2016

4. Oxidative stress in the light-exposed retina and its implication in age-related macular degeneration;Ozawa;Redox Biol.,2020

5. Protective role of glutathione peroxidase 4 in laser-induced choroidal neovascularization in mice;Roggia;PLoS One,2014

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Polydopamine Nanoparticles as Mimicking RPE Melanin for the Protection of Retinal Cells Against Blue Light-Induced Phototoxicity;2024-01-16

2. Mesoporous Cerium Oxide Nanoparticles with High Scavenging Properties of Reactive Oxygen Species for Treating Age‐Related Macular Degeneration;Advanced NanoBiomed Research;2023-11-21